Loading…

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population

BACKGROUND: Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood. OBJECTIVE: To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the gen...

Full description

Bibliographic Details
Main Authors: Tornkvist, Navkiran T., Aziz, Imran, Whitehead, William E., Sperber, Ami D., Palsson, Olafur S., Hreinsson, Jóhann Pall, Simrén, Magnus, Törnblom, Hans
Format: Online Article Text
Language:English
Published: John Wiley and Sons Inc. 2021
Subjects:
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672084/
https://www.ncbi.nlm.nih.gov/pubmed/34599559
http://dx.doi.org/10.1002/ueg2.12153
_version_ 1784615286143451136
author Tornkvist, Navkiran T.
Aziz, Imran
Whitehead, William E.
Sperber, Ami D.
Palsson, Olafur S.
Hreinsson, Jóhann Pall
Simrén, Magnus
Törnblom, Hans
author_facet Tornkvist, Navkiran T.
Aziz, Imran
Whitehead, William E.
Sperber, Ami D.
Palsson, Olafur S.
Hreinsson, Jóhann Pall
Simrén, Magnus
Törnblom, Hans
author_sort Tornkvist, Navkiran T.
collection PubMed
description BACKGROUND: Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood. OBJECTIVE: To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the general population. METHODS: An internet survey was completed by 6,300 individuals equally distributed between United States, United Kingdom and Canada. The Rome IV diagnostic questionnaire was used to identify subjects with IBS. Data on demographics, medical history, gastrointestinal (GI) and non‐GI symptoms, quality of life and health care consumption was collected. RESULTS: A total of 5,931 subjects were included; 274 (4.6%) IBS subjects and 5657 (95.3%) non‐IBS controls. IBS subjects reported more doctor consultations for both GI and other health problems as well as increased use of medication and rate of abdominal surgery (appendectomy excluded). Having healthcare insurance or access to free public healthcare (adjusted odds ratio (AOR) 4.49, 95% confidence interval (CI) 1.31–15.44), followed by high frequency of bloating (AOR 2.65, 95% CI 1.42–4.93) and increasing age (AOR 1.02, 95% CI 1.01–1.05) were found to be independently associated with being an IBS consulter while doctor‐diagnosed IBS subjects were more likely to be female and to report abdominal pain as their most bothersome GI symptom than other consulters with IBS. CONCLUSION: IBS subjects have higher healthcare utilization than non‐IBS controls, medication use and abdominal surgery included. Furthermore, consulters with and without an IBS diagnosis differ in sex distribution and symptom profiles. Hence, awareness of the possibility of unnecessary medical and surgical treatment in IBS subjects and a sex‐related diagnostic bias by doctors is warranted.
format Online
Article
Text
id pubmed-8672084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86720842021-12-21 Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population Tornkvist, Navkiran T. Aziz, Imran Whitehead, William E. Sperber, Ami D. Palsson, Olafur S. Hreinsson, Jóhann Pall Simrén, Magnus Törnblom, Hans United European Gastroenterol J Neurogastroenterology BACKGROUND: Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood. OBJECTIVE: To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the general population. METHODS: An internet survey was completed by 6,300 individuals equally distributed between United States, United Kingdom and Canada. The Rome IV diagnostic questionnaire was used to identify subjects with IBS. Data on demographics, medical history, gastrointestinal (GI) and non‐GI symptoms, quality of life and health care consumption was collected. RESULTS: A total of 5,931 subjects were included; 274 (4.6%) IBS subjects and 5657 (95.3%) non‐IBS controls. IBS subjects reported more doctor consultations for both GI and other health problems as well as increased use of medication and rate of abdominal surgery (appendectomy excluded). Having healthcare insurance or access to free public healthcare (adjusted odds ratio (AOR) 4.49, 95% confidence interval (CI) 1.31–15.44), followed by high frequency of bloating (AOR 2.65, 95% CI 1.42–4.93) and increasing age (AOR 1.02, 95% CI 1.01–1.05) were found to be independently associated with being an IBS consulter while doctor‐diagnosed IBS subjects were more likely to be female and to report abdominal pain as their most bothersome GI symptom than other consulters with IBS. CONCLUSION: IBS subjects have higher healthcare utilization than non‐IBS controls, medication use and abdominal surgery included. Furthermore, consulters with and without an IBS diagnosis differ in sex distribution and symptom profiles. Hence, awareness of the possibility of unnecessary medical and surgical treatment in IBS subjects and a sex‐related diagnostic bias by doctors is warranted. John Wiley and Sons Inc. 2021-10-01 /pmc/articles/PMC8672084/ /pubmed/34599559 http://dx.doi.org/10.1002/ueg2.12153 Text en © 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Neurogastroenterology
Tornkvist, Navkiran T.
Aziz, Imran
Whitehead, William E.
Sperber, Ami D.
Palsson, Olafur S.
Hreinsson, Jóhann Pall
Simrén, Magnus
Törnblom, Hans
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title_full Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title_fullStr Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title_full_unstemmed Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title_short Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
title_sort health care utilization of individuals with rome iv irritable bowel syndrome in the general population
topic Neurogastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672084/
https://www.ncbi.nlm.nih.gov/pubmed/34599559
http://dx.doi.org/10.1002/ueg2.12153
work_keys_str_mv AT tornkvistnavkirant healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT azizimran healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT whiteheadwilliame healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT sperberamid healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT palssonolafurs healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT hreinssonjohannpall healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT simrenmagnus healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation
AT tornblomhans healthcareutilizationofindividualswithromeivirritablebowelsyndromeinthegeneralpopulation